Skip to main content
Toggle navigation
Home
Icon Legend
Livestream
Audience Response
Ticketed Session
Special Event
Traducción Española
Closed Captioning
Scientific Program
New & Evolving Topics
Tweets by 2022 AAP National Conference & Exhibition
Back
Favorite
Yamo Deniz, MD
Vice President, Global Medical Affairs
Regeneron Pharmaceuticals
Abstracts(s):
PC3007: Dupilumab Efficacy in Children with Moderate-to-severe Type 2 Asthma Analyzed by High- or Medium-dose of Inhaled Corticosteroids at Baseline: LIBERTY ASTHMA VOYAGE Study
Monday, October 10, 2022
1:30 PM – 2:30 PM
US PDT
PC3021: The Effect of Allergen Sensitization Status on Dupilumab Efficacy in VOYAGE Pediatric Patients with Uncontrolled, Moderate-to-severe Type 2 Inflammatory Asthma
Monday, October 10, 2022
1:30 PM – 2:30 PM
US PDT
.png)
